Cabergoline Tablets USP 0,5 mg Ingenus Pharmaceuticals

Description

Cabergoline Tablets USP 0,5 mg Ingenus Pharmaceuticals — cabergoline from Ingenus Pharmaceuticals at 0.5 mg. Selective D2 dopamine agonist suppressing pituitary prolactin. Manages prolactin elevation from nandrolone or trenbolone cycles.

Key Benefits

• Dopamine D2 agonist — suppresses prolactin
• On-cycle support for nandrolone and trenbolone users
• Low-dose protocol 0.25 mg twice weekly
• Pull prolactin at week 6 to confirm dose adequacy
• Mood elevation and libido support are bonuses
• Each unit dosed at 5 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 0.25 mg twice weekly for on-cycle prolactin control with deca or tren. Higher doses (0.5 mg 2×/week) for users with elevated baseline prolactin.

How It Works

Ergot-derived dopamine D2 receptor agonist. Suppresses pituitary prolactin secretion. Clinically used for hyperprolactinemia and Parkinson’s. In AAS protocols: counters the prolactin rise from progestagenic compounds (19-nors).

Pharmacokinetics

Plasma half-life approximately 63–69 hours. Twice-weekly dosing sufficient. Steady-state in 2 weeks.

Potential Side Effects

Nausea common initially — take with food. Orthostatic hypotension possible. High-dose long-term use carries cardiac valve concern (documented in Parkinson’s patients on 3+ mg/day — not at AAS-protocol doses).

Cycle & Stacking Guide

On-cycle support with nandrolone, trenbolone, or progestagenic orals (oxymetholone). 0.25 mg 2×/week throughout cycle. Bloodwork at week 6 — target prolactin <15 ng/mL.

Manufacturer Notes

Ingenus Pharmaceuticals is an independent producer in the research-compound market. Before first use, request the batch-specific Certificate of Analysis and confirm the vial’s tamper-evident seal is intact.

Storage & Handling

Store in the original blister or bottle at 15–25 °C, away from direct sunlight, heat, and humidity. Oral preparations lose potency faster if exposed to moisture; keep the desiccant (if included) with the tablets. Keep out of reach of children. For research and educational purposes only.